Search

BREAKING: CTFA CALLS ON GOVERNOR LAMONT TO HALT DISTRIBUTION OF COVID-19 VACCINES TO YOUNG PERSONS



HARTFORD, CT (MAY 24, 2021) - The CT Freedom Alliance, LLC (CTFA) is calling upon Governor Lamont to issue an executive order immediately halting the administration of any of the COVID-19 vaccines to children and young adults. CTFA is making its urgent plea to the Governor after reports surfaced that at least 18 young adults and teens have suffered from myocarditis--a condition rarely seen in healthy young persons--after receiving a COVID-19 vaccine.


Earlier this evening, State Representative Liz Linehan (D-Cheshire) appeared to downplay the significance of these reports, posting on her Facebook page a statement from Dr. Ted O’Connell to NBC San Diego, in which O’Connell alleged that “the rates that we’re seeing of myocarditis are no higher than what we would experience normally.” CTFA President Dawn Jolly fiercely pushed back against that claim.

“The truth is, myocarditis is rarely seen in children, with an estimated 1 to 2 cases per every 100,000 children(1),” Jolly said. “So to see 18 cases in such a short span of time in Connecticut alone, is deeply troubling. Even more troubling, though, is the fact that we can’t be sure what long-term effects these children will experience as a result of developing this serious condition. In light of this disturbing news, the Governor has a duty to stop this immediately.”


According to research, mortality rates for children with acute myocarditis range from 6 to 14 percent(2), with between 5 and 20 percent of acute cases requiring heart transplantation.(3)


Sources:


1 Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, Davis AM, Kahler SG, Chow CW, Wilkinson JL, Weintraub RG; National Australian Childhood Cardiomyopathy Study. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003 Apr 24;348(17):1639-46. doi: 10.1056/NEJMoa021737. PMID: 12711738.

Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003 Apr 24;348(17):1647-55. doi: 10.1056/NEJMoa021715. PMID: 12711739.

Arola A, Pikkarainen E, Sipilä JO, Pykäri J, Rautava P, Kytö V. Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland. J Am Heart Assoc. 2017 Nov 18;6(11):e005306. doi: 10.1161/JAHA.116.005306. PMID: 29151030; PMCID: PMC5721735.

Wu MH, Wu ET, Wang CC, Lu F, Chen HC, Kao FY, Huang SK. Contemporary Postnatal Incidence of Acquiring Acute Myocarditis by Age 15 Years and the Outcomes From a Nationwide Birth Cohort. Pediatr Crit Care Med. 2017 Dec;18(12):1153-1158. doi: 10.1097/PCC.0000000000001363. PMID: 29068909.

Kim J, Cho MJ. Acute Myocarditis in Children: a 10-year Nationwide Study (2007-2016) based on the Health Insurance Review and Assessment Service Database in Korea. Korean Circ J. 2020 Nov;50(11):1013-1022. doi: 10.4070/kcj.2020.0108. Epub 2020 Aug 7. PMID: 32812406; PMCID: PMC7596206.

2 Ghelani SJ, Spaeder MC, Pastor W, Spurney CF, Klugman D. Demographics, trends, and outcomes in pediatric acute myocarditis in the United States, 2006 to 2011. Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):622-7. doi: 10.1161/CIRCOUTCOMES.112.965749. Epub 2012 Jul 24. PMID: 22828827.

Wu MH, Wu ET, Wang CC, Lu F, Chen HC, Kao FY, Huang SK. Contemporary Postnatal Incidence of Acquiring Acute Myocarditis by Age 15 Years and the Outcomes From a Nationwide Birth Cohort. Pediatr Crit Care Med. 2017 Dec;18(12):1153-1158. doi: 10.1097/PCC.0000000000001363. PMID: 29068909.

Anderson BR, Silver ES, Richmond ME, Liberman L. Usefulness of arrhythmias as predictors of death and resource utilization in children with myocarditis. Am J Cardiol. 2014 Nov 1;114(9):1400-5. doi: 10.1016/j.amjcard.2014.07.074. Epub 2014 Aug 12. PMID: 25200339.

Klugman D, Berger JT, Sable CA, He J, Khandelwal SG, Slonim AD. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol. 2010 Feb;31(2):222-8. doi: 10.1007/s00246-009-9589-9. PMID: 19936586.

Gagliardi MG, Bevilacqua M, Bassano C, Leonardi B, Boldrini R, Camassei FD, Fierabracci A, Ugazio AG, Bottazzo GF. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart. 2004 Oct;90(10):1167-71. doi: 10.1136/hrt.2003.026641. PMID: 15367516; PMCID: PMC1768474.

Lee KJ, McCrindle BW, Bohn DJ, Wilson GJ, Taylor GP, Freedom RM, Smallhorn JF, Benson LN. Clinical outcomes of acute myocarditis in childhood. Heart. 1999 Aug;82(2):226-33. doi: 10.1136/hrt.82.2.226. PMID: 10409542; PMCID: PMC1729152.

English RF, Janosky JE, Ettedgui JA, Webber SA. Outcomes for children with acute myocarditis. Cardiol Young. 2004 Oct;14(5):488-93. doi: 10.1017/S1047951104005049. PMID: 15680069.

3 Ghelani SJ, Spaeder MC, Pastor W, Spurney CF, Klugman D. Demographics, trends, and outcomes in pediatric acute myocarditis in the United States, 2006 to 2011. Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):622-7. doi: 10.1161/CIRCOUTCOMES.112.965749. Epub 2012 Jul 24. PMID: 22828827.


Butts RJ, Boyle GJ, Deshpande SR, Gambetta K, Knecht KR, Prada-Ruiz CA, Richmond ME, West SC, Lal AK. Characteristics of Clinically Diagnosed Pediatric Myocarditis in a Contemporary Multi-Center Cohort. Pediatr Cardiol. 2017 Aug;38(6):1175-1182. doi: 10.1007/s00246-017-1638-1. Epub 2017 May 23. PMID: 28536746.

Foerster SR, Canter CE, Cinar A, Sleeper LA, Webber SA, Pahl E, Kantor PF, Alvarez JA, Colan SD, Jefferies JL, Lamour JM, Margossian R, Messere JE, Rusconi PG, Shaddy RE, Towbin JA, Wilkinson JD, Lipshultz SE. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail. 2010 Nov;3(6):689-97. doi: 10.1161/CIRCHEARTFAILURE.109.902833. Epub 2010 Sep 10. PMID: 20833772.

3,455 views0 comments